Kiernan DeAngelis

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

Gary T. Ferguson, Klaus F. Rabe, Fernando J. Martínez et al. · The Lancet Respiratory Medicine · 2018 · 400 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study

Edward Kerwin, Gary T. Ferguson, Mindy Mo et al. · Respiratory Research · 2019 · 53 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

<p>Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD</p>

Masakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue et al. · International Journal of COPD · 2019 · 44 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects

Samuel Israel, Ashish Kumar, Kiernan DeAngelis et al. · European Journal of Pharmaceutical Sciences · 2020 · 28 citations · Full text

Pharmacy, Nuclear Medicine, Pharmacology +17

<p>Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study</p>

Masakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue et al. · International Journal of COPD · 2019 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17